TGFB1 and neoplasm: In the late stage of tumor progression, when the tumor cytokine TGF-β signaling pathway is inactivated or the cell cycle is abnormally regulated and becomes resistant to the growth inhibition of TGF-β, the effect of TGF-β has a pro-tumor effect.